NeoChord Set To Start US Trial Of Artificial Chordae Tendinae System

NeoChord is now training 20 US centers in preparation for a US randomized clinical trial to support a PMA for its NeoChord DS1000 artificial chordae delivery system for minimally invasive mitral valve repair.

NeoChord is now training 20 US centers in preparation for a US randomized clinical trial to support a PMA for its NeoChord DS1000 artificial chordae delivery system for minimally invasive mitral valve repair.

The NeoChord DS1000 is a tool for the transapical delivery of expanded polytetrafluoroethylene sutures to replace damaged chordae tendinae –...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight